Market Place
Sourcing Support
Roche doubles down on promising inflammation field with Inflazome buy
25 Sep 2020 //
SEEKING ALPHA
Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position
22 Sep 2020 //
FIERCE BIOTECH
Inflazome Announces Its Acquisition By Roche
21 Sep 2020 //
BUSINESSWIRE
FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for (CAPS)
14 Jul 2020 //
BUSINESSLWIRE
FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment
14 Jul 2020 //
BUSINESSWIRE
Inzomelid completes Ph I studies and shows +ve results treatment of Cryopyrin
26 Mar 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.